SCHEMBL22887

SCHEMBL22887

CCO[C]1CCN(c2ccc(Cl)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
ADRB1 P08588 1/20 0.46
HTR3A P46098 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
KMT2A Q03164 1/20 0.44
CHIA Q9BZP6 1/20 0.44
LTA4H P09960 2/20 0.42
DRD4 P21917 1/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
HTR2A P28223 1/20 0.42
DRD3 P35462 1/20 0.42
TMEM97 Q5BJF2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL293213 0.80 HTR3E (0.50) KDM4EGAASIGMAR1HTR3EHTR3B
SCHEMBL5846175 0.75 KDM4E (0.48) KDM4EGAAADRB1DRD4LMNA
SCHEMBL6031303 0.72 DRD2 (0.71) KDM4ESIGMAR1DRD4MAPTHTR1A
SCHEMBL29998630 0.72 HTR3E (0.70) KDM4EGAASIGMAR1HTR3EHTR3B
SCHEMBL870704 0.72 HTR3E (0.70) KDM4EGAASIGMAR1HTR3EHTR3B
SCHEMBL22888 0.71 KMT2A (0.50) KDM4EGAASIGMAR1HTR3EHTR3B
Hydrochloric Acid SCHEMBL6031981 0.71 DRD2 (0.70) KDM4ESIGMAR1DRD4MAPTHTR1A
SCHEMBL7606468 0.71 MAPT (0.57) KDM4EGAASIGMAR1HTR3EHTR3B
SCHEMBL10891766 0.71 KMT2A (0.71) KDM4EGAAKMT2ACHIADRD4
SCHEMBL710770 0.70 HTR3E (0.55) SIGMAR1HTR3EHTR3BADRB1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192751-A1 METHOD FOR THE PREPARATION OF OLIGONUCLEOTIDES THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV (CA) 2023-06-22 US claimed
CN-106977567-B Oligonucleotide with protected base moiety 味之素株式会社 2021-02-02 CN claimed
US-10287313-B2 RNA monomers containing 0-acetal levulinyl ester groups and their use in RNA microarrays THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2019-05-14 US claimed
US-20160340382-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2016-11-24 US claimed
EP-2334692-B1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS UNIV MCGILL (CA) 2016-04-13 EP claimed
US-9249175-B2 RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays THE ROYAL INSTITUTE FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2016-02-02 US claimed
US-20120178638-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-07-12 US claimed
EP-2334692-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS The Royal Institution for the Advancement of Learning / McGill University (CA) 2011-06-22 EP claimed
WO-2010025566-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2010-03-11 WO claimed
WO-2024073349-A2 CLEAVABLE LINKERS FOR THE TETHERING OF POLYMERASES TO NUCLEOTIDES ANSA BIOTECHNOLOGIES, INC. (US) 2024-04-04 WO disclosed
CN-110337495-B Single-stranded oligonucleotides 日产化学株式会社 2024-03-29 CN disclosed
US-20240084296-A1 SINGLE-STRANDED OLIGONUCLEOTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-03-14 US disclosed
US-20240018180-A1 OLIGONUCLEOTIDE PRODUCTION METHOD AJINOMOTO CO., INC. (JP) 2024-01-18 US disclosed
EP-4293035-A1 OLIGONUCLEOTIDE PRODUCTION METHOD AJINOMOTO CO., INC. (JP) 2023-12-20 EP disclosed
WO-2010025566-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2010-03-11 WO disclosed
WO-2009064115-A1 PREPARATION OF NUCLEOTIDE OLIGOMER SAMCHULLY PHARM. CO., LTD. (KR) 2009-05-22 WO disclosed
EP-1899467-A2 MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCES IMMUNOSTIMULATORY ACTIVITY Coley Pharmaceutical GmbH (DE) 2008-03-19 EP disclosed
US-20080064867-A1 PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES SIGMA ALDRICH COMPANY (US) 2008-03-13 US disclosed
WO-2006116458-A2 MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCES IMMUNOSTIMULATORY ACTIVITY COLEY PHARMACEUTICAL GMBH (DE) 2006-11-02 WO disclosed
US-20060241076-A1 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity COLEY PHARMACEUTICAL GMBH (DE) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287313-B2 RNA monomers containing 0-acetal levulinyl ester groups and their use in RNA microarrays EFTUD2, RNMT, NSUN2 KDM4E 924/4885GAA 1382/4885SIGMAR1 2544/4885
US-20080064867-A1 PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES RNGTT, DUT, ADAR KDM4E 1717/4885GAA 661/4885SIGMAR1 3442/4885
US-20160340382-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS EFTUD2, RNMT, RNGTT KDM4E 911/4885GAA 1477/4885SIGMAR1 2814/4885
US-20060241076-A1 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity TLR3, TLR8, TLR9 KDM4E 1276/4885GAA 1137/4885SIGMAR1 2086/4885
US-20240084296-A1 SINGLE-STRANDED OLIGONUCLEOTIDE MLX, ZFX, UPF1 KDM4E 2321/4885GAA 1551/4885SIGMAR1 804/4885
US-20240018180-A1 OLIGONUCLEOTIDE PRODUCTION METHOD RNGTT, NOX4, POLRMT KDM4E 3319/4885GAA 3338/4885SIGMAR1 2456/4885
US-20120178638-A1 RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS EFTUD2, RNMT, RNGTT KDM4E 911/4885GAA 1477/4885SIGMAR1 2814/4885
US-20230192751-A1 METHOD FOR THE PREPARATION OF OLIGONUCLEOTIDES POLN, POLRMT, POLI KDM4E 4513/4885GAA 2244/4885SIGMAR1 4733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.